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Abstract
Background: Ganglioneuroma (GN) of the adult is a rare benign tumour originating from neural crest-derived cells.
In most cases, GN is found in the mediastinum or retroperitoneum incidentally and may present with unspecific
symptoms caused by space-occupying effects. The correct diagnosis of a retroperitoneal mass is still a challenge.
Nevertheless, a preoperatively confirmed diagnosis of GN may support the concept of a less radical approach and
may help to prevent unnecessary morbidity or loss of function.
Case presentation: We report a case of a symptomatic retroperitoneal paravertebral GN in a 33-year-old woman.
She has been referred with abdominal discomfort, lancinating pain in the right leg, headache and nausea. Magnetic
resonance imaging revealed a solid paravertebral tumour adjacent to the psoas muscle. Computed tomography-guided
core needle biopsy yielded the diagnosis of GN. The tumour was resected completely via a laparotomy.
Immunohistopathological examinations confirmed a benign GN.
Conclusions: Diagnostic studies and therapeutic interventions of retroperitoneal GN are discussed. In our case, a core
needle biopsy preceding complete resection was helpful to prevent too extensive surgical approach.
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Background
Benign ganglioneuroma (GN) contains mature auto-
nomic ganglion cells including satellite cells and long
axonal processes as well as Schwann cells [1–3].
Those tumours originate from neural crest-derived
cells which form the adrenal medulla and the sympa-
thetic nervous system during embryonic development.
Hence, they mainly arise in the mediastinum, retro-
peritoneum and pelvis where sympathetic ganglia are
localized. Alike neuroblastoma and ganglioneuroblas-
toma, GN is supposed to represent the most mature
neuroblastic tumour since ganglion cells that originate
from neuroblasts are present in all of these tumours.
Maturation of a neuroblastoma into a ganglioneuroma
or ganglioneuroblastoma has been commonly de-
scribed in the literature [1–3].
GN occurs in children and young adults, and median
age at diagnosis is 7 years [4–7]. Distribution between
males and females vary from a preference of the female
gender [5] to no gender difference [7]. A higher fre-
quency is reported in patients with multiple endocrine
neoplasia type II and neurofibromatosis type 1. Due to
their slow growth, most GNs are found incidentally.
Most patients experience long-term disease-free survival
even after incomplete resection [5, 7]. Malignant trans-
formation is rare [8]. Since only a minority of GN are
functional, distinct clinical symptoms are missing [4, 5].
Rarely, these tumours may produce hormones, such as
catecholamines, vasointestinal peptides and androgens
[7]. Radiographically, GN usually present as well-defined
solid masses and do not contain cysts as opposed to
neuroblastoma and ganglioneuroblastoma [6, 9]. Non-
enhancement or slight enhancement in arterial phase
and progressive mild enhancement in delayed phase is
seen [6, 10]. At MR imaging, GN has low signal intensity
on T1-weighted images and high signal intensity on T2
weighted images [6]. Distinct radiological features are
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lacking. Therefore, diagnosis can be challenging and is
more precisely achieved by histological examination after
resection. An imaging-guided core needle biopsy can be
a reasonable approach to enable a reliable diagnosis be-
fore major surgery.
Case presentation
A 33 year-old woman presented with a history of moder-
ate abdominal pain and recurrent nausea. Recently, she
experienced lancinating pain in her right leg and hot
flashes. She did not report unintended weight loss,
fatigue or fever. Previously, she had undergone body
contouring plastic surgery after a weight loss of 35 kg.
She carried a levonorgestrel-releasing intrauterine device
(IUD) for several months. Computed tomography (CT)
revealed a retroperitoneal mass adjacent to the right
psoas muscle. Since a retroperitoneal sarcoma was sus-
pected, the patient was referred to our institution. The
laboratory test yielded normal blood levels of chromo-
granin A, neuron-specific enolase, CA15-3, and CA125.
Urine and blood samples did not show elevated produc-
tion of catecholamines, vasoactive intestinal peptide or
androgens. Gynaecological examination including trans-
vaginal ultrasound showed normal findings and con-
firmed the correct position of the IUD. Magnetic
resonance imaging (MRI) demonstrated a solid tumour
(68 × 35 × 28 mm) between the anterior circumference
of the right psoas muscle and the anterior surface of the
third and fourth lumbar vertebra as well as laterally ex-
tending to the to the right ureter, the inferior vena cava
and right common iliac vein (Fig. 1). A CT-guided per-
cutaneous core needle biopsy was performed to allow a
histological diagnosis before surgery. The core biopsies
contained only mature tissue with bundles of Schwann
cells. Prominent, but also mature, ganglion cells were
within the stroma, and there were no other histological
signs of malignancy. Therefore, histopathological exam-
ination assumed a GN (Fig. 2).
Institutional interdisciplinary tumour board recom-
mended a primary surgical resection. Prior to surgery, a
double J stent was placed in the right ureter. Explorative
laparotomy exposed the paravertebral tumour extending
to the lower pole of the right kidney. The uterus and the
adnexa with ovaries were without any pathological
findings. After ureterolysis, the tumour was cautiously
dissected from adherent structures such as the right
common iliac vein and the kidney which were both
not infiltrated by the tumour. Finally, the tumour was
completely removed by means of blunt and sharp dis-
section and bipolar coagulation under a surgical
microscope (the microscope has been used to save
most of the branches of the lumbar plexus and nerves
of the sympathetic trunk which was partly incorpo-
rated into the GN).
Fig. 1 Preoperative coronal MRI showing a 68 × 35 × 28 mm solid mass anterior to the right psoas muscle (yellow arrow). The tumour was also
detected by ultrasound and CT (short yellow arrow, white arrow)
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Neuropathological examination of the tumour estab-
lished the diagnosis of a typical GN with extremely
low proliferation (Ki67 less than 1 %) and no evi-
dence of a ganglioneuroblastoma. Within the tumour,
a ganglion with mature ganglion cells was embedded
and a peripheral nerve was observed being penetrated
by the tumour (Fig. 3).
The postoperative course was uneventful. After sur-
gery, the patient reported heat sensations of stocking
distribution in the right lower leg. Follow-up 4 months
*
Fig. 2 Representative part of the GN with a ganglion enclosed (yellow arrow, magnification ×2). Mature ganglion cells with small satellite cells are
demonstrated in the insert (magnification ×20, haematoxylin-eosin)
Fig. 3 Tumour mass with a normal appearing ganglion (right to dashed line) merging into diffuse tumour areas (left to dashed line). Typically wavy
cells with comma-shaped small nuclei prevail (haematoxylin-eosin, magnification ×10)
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after surgery still revealed a small hyperthermic area and
stocking-like heat sensations in the right lower leg that
was interpreted to relate to a lesion of the sympathetic
trunk partly incorporated into the GN. MRI at follow-up
did not show tumour recurrence.
Discussion
Clinical manifestations of GNs are diverse. In most cases,
symptoms result from compression or displacement by
the growing tumour and represent disturbances such as
disruption of venous flow [11] and lower abdominal pain
[12]. Most GNs are located mediastinal or retroperitoneal.
In addition, a primary intraosseous GN of the sacrum has
been described as a rare manifestation [13]. GN usually
represents a non-secreting tumour. Occasionally, GN may
release hormones that can cause diarrhoea, sweating and
arterial hypertension [14]. Tumours may also cause tenes-
muses and weight loss [15]. In our case, we additionally
observed lancinating pain in a leg most likely caused by ir-
ritation of branches of the lumbar plexus running along
the anterior surface of the psoas muscle.
Important differential diagnoses of retroperitoneal
masses like the GN are retroperitoneal soft tissue sarcoma,
and retroperitoneal fibrosis, and rarely lymphoma, a pri-
mary germ cell tumour, or metastatic testicular cancer.
The complete removal of the GN is described as
adequate therapy with an excellent prognosis. Never-
theless, surgical morbidity has to be considered. In a
retrospective series of 146 children with GN, surgical
tumour resection resulted in an excellent long-term
survival, but, nevertheless, 22 of the 146 patients (15 %)
suffered surgery-related complications, of which two were
fatal and seven were severe (e.g. Horner syndrome, rup-
ture of thoracic aorta and thoracic haemorrhage) [5]. Re-
sidual GN after incomplete resection remains stable for
years without malignant transformation [5]. In addition,
Retrosi et al. did not observe recurrences after incomplete
excision in a series of 23 children with thoracic (n = 14),
abdominal (n = 7) or pelvic GN (n = 3) [16]. Surgical com-
plication rate reached 30 % [16]. Therefore, Retrosi and
De Bernadi recommended less radical surgery in child-
hood GN to reduce surgery-related morbidity and mortal-
ity [5, 16]. Even a watchful waiting could be an option in
selected cases after secured diagnosis. Interdisciplinary
discussion and image-guided biopsy prior to surgery is
recommended to prevent unnecessary expanded surgical
approaches with significant postoperative morbidity. From
our experience, we would suggest surgical resection of
GN, but with a less radical approach in order to preserve
the adjacent organs and structures where appropriate.
Conclusions
Ganglioneuroma is a benign, rare tumour with an excel-
lent prognosis in long-term survival even after incomplete
resection. Therefore, a limited surgical resection to pre-
vent postoperative morbidity might be appropriate in se-
lected cases. An image-guided biopsy prior to surgery can
establish a histological diagnosis and prevent unneeded
extensive surgery.
Abbreviations
CT, computed tomography; GN, ganglioneuroma; IUD, intrauterine device;





Availability of data and material
Upon request and on condition of the patients consent all data and material
will be available to any scientist.
Authors’ contributions
All authors participated in the conception and design of the study. CP and
RS drafted the manuscript. CP, EG, AS and RS participated in the care of the
patient. AH and EJG offered the pathological data. CP, AH, EG, EJG, AS and
RS were involved in the final editing. All authors read and approved the final
manuscript.
Competing interests
The authors declare that they have no competing interests.
Consent for publication
Written informed consent was obtained from the patient for publication of
the case report and any accompanying images.
Ethics approval and consent to participate
Not applicable.
Author details
1Department of General, Visceral and Cancer Surgery, HELIOS Klinikum
Berlin-Buch, Berlin, Germany. 2Faculty of Health, Witten/Herdecke University,
Witten, Germany. 3Institute of Pathology, Health Care Centre of the Municipal
Hospital Brandenburg, Clinic of Medical University of Brandenburg,
Brandenburg, Germany. 4Institute of Neuropathology, University Hospital
Münster, Münster, Germany. 5Institute of Pathology, HELIOS Klinikum
Berlin-Buch, Berlin, Germany. 6Institute of Radiology, HELIOS Klinikum
Berlin-Buch, Berlin, Germany. 7Department of Neurosurgery, HELIOS Klinikum
Berlin-Buch, Berlin, Germany.
Received: 1 April 2016 Accepted: 20 July 2016
References
1. Shimada H, Ambros IM, Dehner LP, Hata J, Joshi VV, Roald B. Terminology
and morphologic criteria of neuroblastic tumors: recommendations by the
International Neuroblastoma Pathology Committee. Cancer. 1999;86:349–63.
2. Shimada H, Ambros IM, Dehner LP, Hata J, Joshi VV, Roald B, Stram DO,
Gerbing RB, Lukens JN, Matthay KK, Castleberry RP. The International
Neuroblastoma Pathology Classification (the Shimada system). Cancer. 1999;
86:364–72.
3. Ambros IM, Hata J, Joshi VV, Roald B, Dehner LP, Tüchler H, Pötschger U,
Shimada H. Morphologic features of neuroblastoma (Schwannian stroma-
poor tumors) in clinically favorable and unfavorable groups. Cancer. 2002;94:
1574–83.
4. Hayes FA, Green AA, Rao BN. Clinical manifestations of ganglioneuroma.
Cancer. 1989;63:1211–4.
5. De Bernardi B, Gambini C, Haupt R, Granata C, Rizzo A, Conte M, Tonini GP,
Bianchi M, Giuliano M, Luksch R, Prete A, Viscardi E, Garaventa A, Sementa
AR, Bruzzi P, Angelini P. Retrospective study of childhood ganglioneuroma. J
Clin Oncol. 2008;26:1710–16.
Paasch et al. World Journal of Surgical Oncology  (2016) 14:194 Page 4 of 5
6. Lonergan GJ, Schwab CM, Suarez ES, Carlson CL. Neuroblastoma,
ganglioneuroblastoma, and ganglioneuroma: radiologic-pathologic
correlation. Radiographics. 2002;22(4):911–34.
7. Geoerger B, Hero B, Harms D, Grebe J, Scheidhauer K, Berthold F. Metabolic
activity and clinical features of primary ganglioneuromas. Cancer. 2001;
91(10):1905–13.
8. Kulkarni AV, Bilbao JM, Cusimano MD, Muller PJ. Malignant transformation
of ganglioneuroma into spinal neuroblastoma in an adult. J Neurosurg.
1998;88(2):324–7.
9. Ichikawa T, Ohtomo K, Araki T, Fujimoto H, Nemoto K, Nanbu A, Onoue M,
Aoki K. Ganglioneuroma: computed tomography and magnetic resonance
features. Br J Radiol. 1996;69(818):114–21.
10. Guan YB, Zhang WD, Zeng QS, Chen GQ, He JX. CT and MRI findings of
thoracic ganglioneuroma. Br J Radiol. 2012;85(1016):e365–72.
11. Brueck M, Bandorski D, Rauber K, Kramer W. Unilateral swollen leg caused
by a retroperitoneal ganglioneuroma. Dtsch Med Wochenschr. 2006;38:
2079–82.
12. Gültekin M, Dursun P, Salman C, Ozyüncü O, Saglam A, Küçükali T, Ayhan A.
Ganglioneuroma mimicking ovarian tumor: a report of a case and review of
the ganglioneuromas. Arch Gynecol Obstet. 2005;271:66–8.
13. Wu CS, Wang XW, Qin T, Chen Z, Sun S, Li JM, Liu HL, Feng H, Han JQ.
Primary intraosseous ganglioneuromatous paraganglioma of the sacrum
with immunopositivity for cytokeratin. Eur Rev Med Pharmacol Sci. 2015;19:
931–5.
14. Bjellerup P, Theodorsson E, Kogner P. Somatostatin and vasoactive intestinal
peptide in neuroblastoma and ganglioneuroma: chromatographic
characterization and release during surgery. Eur J Cancer. 1995;31A:481–5.
15. Nishinari K, Wolosker N, Yazbek G, Toshihiko W, Lopes A. Idiopathic
aneurysm of inferior vena cava associated with retroperitoneal
ganglioneuroma: case report. J Vasc Surg. 2003;37:895–8.
16. Retrosi G, Bishay M, Kiely EM, Sebire NJ, Anderson J, Elliott M, Drake DP,
Coppi PD, Eaton S, Pierro A. Morbidity after ganglioneuroma excision: is
surgery necessary? Eur J Pediatr Surg. 2011;21:33–7.
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
Paasch et al. World Journal of Surgical Oncology  (2016) 14:194 Page 5 of 5
